Current liabilities increased 15.0%
Current liabilities changed +15.0% from the comparable as-filed period. The change ranks at the 75th percentile of 4 prior comparable changes.
Ranked by interpretable importance, issuer history, magnitude, and accounting profile. No directional recommendation.
Current liabilities changed +15.0% from the comparable as-filed period. The change ranks at the 75th percentile of 4 prior comparable changes.
Operating income changed -521.7% from the comparable as-filed period. Relative percentage is de-emphasized because the comparison has a sign change.
Working capital / assets changed -294 basis points from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes.
Revenue changed +12.3% from the comparable as-filed period.
Net debt changed -12.9% from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
Free-cash-flow margin changed +675 basis points from the comparable as-filed period.
Operating cash-flow margin changed +687 basis points from the comparable as-filed period.
Stock-based compensation changed -36.4% from the comparable as-filed period.
Debt / revenue changed -4365 basis points from the comparable as-filed period.
Total assets changed -11.8% from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes.
Current long-term debt changed +1077.6% from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes. Relative percentage is de-emphasized because the comparison has a low base.
Gross debt changed -11.9% from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes.
Noncurrent long-term debt changed -11.9% from the comparable as-filed period.
Reported total debt changed -11.9% from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes.
Capex / revenue changed +12 basis points from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
Shares outstanding changed -2.9% from the comparable as-filed period. The change ranks at the 12th percentile of 8 prior comparable changes.
Cash & equivalents changed -4.8% from the comparable as-filed period.
Cash / debt changed +100 basis points from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
Current ratio changed -12.6% from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes.
Capital expenditure changed +18.8% from the comparable as-filed period.
Inventory changed -5.4% from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes.
SBC / revenue changed -9 basis points from the comparable as-filed period.
Research & development changed +2.0% from the comparable as-filed period.
Selling, general & administrative changed -5.6% from the comparable as-filed period.
R&D / revenue changed -25 basis points from the comparable as-filed period.
Current assets changed +0.5% from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes.
Debt / assets changed -3 basis points from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes.
Method Importance combines metric-family relevance, magnitude, issuer-history unusualness, persistence, and financial-statement significance. It is analytical prioritization, not a legal materiality conclusion or investment signal.